CNS vs IVZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
CNS
IVZ
Investment Advisor Scores
IVZ
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | IVZ | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.4502 | 9.5147 | IVZ |
| PEG Ratio | 1.6881 | 0.9008 | IVZ |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 12.2% | 20.5% | IVZ |
| Earnings Growth | 31.9% | 35.0% | IVZ |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.9/100 | 61.4/100 | IVZ |
| Profit Margin | 28.8% | -0.9% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
MarkdownPrice below a falling SMA50 (slope -1.8%), weak momentum, RSI 36
IVZ
NeutralMixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | CNS | IVZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 18.4 | 9.3 |
| Trailing P/E | 22.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 0.5% | 0.3% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 3.26 | -0.68 |
| Dividend Yield | 0.04% | 0.03% |